← Back to Search

Daily Blood Pressure Monitoring for High Blood Pressure

N/A

Waitlist Available

Led By Maarten Lansberg, MD, PhD

Research Sponsored by AIRx Health, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up every 4-week period over 24 weeks.

Awards & highlights

Study Summary

This trial will test whether a software tool can help doctors manage systolic blood pressure in stroke and TIA patients remotely.

Eligible Conditions

High Blood Pressure
Stroke

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ every 4-week period over 24 weeks.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~every 4-week period over 24 weeks.

This trial's timeline: 3 weeks for screening, Varies for treatment, and every 4-week period over 24 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent patients within target BP

Secondary outcome measures

Change in average systolic blood pressure

Change in number of antihypertensive drugs

Change in number of classes of antihypertensive drugs

+6 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Hypertensive Patients Monitored DailyExperimental Treatment1 Intervention

Physicians utilize DailyDoctor remote monitoring platform to virtually monitor daily BP of patients. Physicians use their independent medical judgement to recommend any clinical follow up or adjustment in medications/prescriptions for any patients whose daily reporting of BP triggers an alert based on physician-driven alert thresholds.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

AIRx Health, Inc.Lead Sponsor

Stanford UniversityOTHER

2,386 Previous Clinical Trials

17,333,958 Total Patients Enrolled

Maarten Lansberg, MD, PhDPrincipal InvestigatorStanford University

1 Previous Clinical Trials

182 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the research presently enrolling participants?

"As revealed by clinicaltrials.gov, this research study is no longer seeking participants; since it was last updated on April 1st 2022. However, there are 749 other trials currently recruiting patients at present."

Answered by AI

Recent research and studies

JAMA NeurologyJournal

Effect of Standard Vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke

Kitagawa, Kazuo, Yasumasa Yamamoto, Hisatomi Arima, Toshiki Maeda, Norio Sunami, Takao Kanzawa, Kazuo Eguchi, et al.. 2019. “Effect of Standard Vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke”. JAMA Neurology. American Medical Association (AMA). doi:10.1001/jamaneurol.2019.2167.

Clinical Journal of the American Society of NephrologyJournal

Surrogate End Points for Clinical Trials of Kidney Disease Progression

Stevens, Lesley A., Tom Greene, and Andrew S. Levey. 2006. “Surrogate End Points for Clinical Trials of Kidney Disease Progression”. Clinical Journal of the American Society of Nephrology. American Society of Nephrology (ASN). doi:10.2215/cjn.00600206.

Scientific ReportsJournal

Effectiveness of Telemonitoring in Patients with Chronic Obstructive Pulmonary Disease in Taiwan-a Randomized Controlled Trial

Ho, Te-Wei, The HINT Study Group, Chun-Ta Huang, Herng-Chia Chiu, Sheng-Yuan Ruan, Yi-Ju Tsai, Chong-Jen Yu, and Feipei Lai. 2016. “Effectiveness of Telemonitoring in Patients with Chronic Obstructive Pulmonary Disease in Taiwan-a Randomized Controlled Trial”. Scientific Reports. Springer Science and Business Media LLC. doi:10.1038/srep23797.

TrialsJournal